Posts by: admin

admin

August 22, 2014August 22, 2014

Health Groups Call On FDA to Finalize Rule Regulating All Tobacco Products by April 2015 and Reject Exemption for Premium Cigars

News

After the Food and Drug Administration issued a proposed rule to regulate all tobacco products, 24 leading public health and medical organizations representing over 560,000 healthcare and public health professionals ... Read more

August 19, 2014August 19, 2014

New National Cancer Institute Trial Focuses On Preventing Recurrence in Two Types of Lung Cancer

Lung cancer News, News

A new trial promoted by the National Cancer Institute will evaluate whether targeting erlotinib and crizotinib drugs used against epidermal growth factor receptor (EGFR) and anapestic lymphoma kinase (ALK) gene changes in lung ... Read more

August 18, 2014August 18, 2014

Previous Respiratory Diseases Are Risk Factor For Lung Cancer

Lung cancer News, News

Although respiratory conditions and lung cancer often simultaneously occur in a patient, few studies have investigated the link between these conditions. However, a new study, recently published in the American Thoracic ... Read more

August 15, 2014August 18, 2014

RNAs Could Stop Tumor Growth in Lung Cancer Patients

Lung cancer News, News

Small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), have the potential to serve as therapeutic agents specifically directed to inhibit tumor growth. Nonetheless, the delivering systems ... Read more

August 12, 2014August 13, 2014

New Study Compares Immunotherapy and Chemotherapy Effects on Non-small Cell Lung Cancer

Lung cancer News, News

A new clinical study currently enrolling at Houston Methodist Hospital is seeking to compare the effects an experimental immunotherapy drug and an approved chemotherapy drug have on the increase in non-small cell lung cancer, which represents ... Read more

August 11, 2014August 11, 2014

New Study Sheds Light on Decline of Lung Cancer in America

Lung cancer News, News

A new epidemiological study entitled “U.S. lung cancer trends by histologic type” was published in the peer-reviewed journal Cancer, whereby a team of scientists from the National Cancer Institute concluded ... Read more

August 7, 2014August 7, 2014

QIAGEN, AstraZeneca To Collaborate On Liquid Biopsy-Based Companion Diagnostic For Improved Lung Cancer EGFR Mutation Profiling

Lung cancer News, News

QUIAGEN, a global provider of molecular Sample & Assay Technologies, recently announced a new collaboration with drug developer AstraZeneca in order to further develop and commercialize a liquid biopsy-based companion diagnostic complementing IRESSA, AstraZeneca’s targeted therapy for non-small ... Read more

August 1, 2014August 30, 2014

Combining Treatment Benefits Lung Cancer Patients With Resistance to Anticancer Therapies

Lung cancer News, News

Combining afatinib and cetuximab produced positive clinical responses in lung cancer patients with epidermal growth factor receptor (EGFR) mutations that had developed resistance to EGFR inhibitors erlotinib and gefitinib. These ... Read more

July 24, 2014July 24, 2014

Batu Biologicals Announced its ValloVax Immunotherapeutic For Lung Cancer

Lung cancer News, News

Batu Biologicals recently announced its flagship product ValloVax™, a novel cancer vaccine that trains the immune system to selectively kill blood vessels that are feeding tumors. Batu Biologicals is an ... Read more

July 23, 2014

New Research Reveals AZD3965 Therapy May Be Viable For Treating Small Cell Lung Cancer

News

Scientists from the Cancer Research UK Manchester Institute, based at The University of Manchester, and part of the Manchester Cancer Research Centre, have tested a new drug with the potential ... Read more